Wednesday after President Donald Trump announced tariffs for all trading partners as investors fretted over increased prices ...

At the market, a federal complaint shows investigators found vendors selling controlled substances, including “MDMA, cocaine, ketamine, LSD, marijuana, and psilocybin mushrooms.” ...

A large illicit drug market has been shut down by the Department of Homeland Security and the DEA after a weekend raid on a warehouse in Gresham.

President Donald Trump made good on his threat of announcing new and steeper tariffs during a Wednesday afternoon White House ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $126.67, along ...

Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express ...

Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...

A unanimous Supreme Court on Wednesday backed the Food and Drug Administration's refusal to authorize the sale of ...

Arcus Biosciences is a high-risk speculation with major upcoming catalysts, despite stock declines and Gilead's exit from the ...

“These findings reaffirm that the current Ocrevus IV 600 mg is optimally dosed to significantly slow disability progression,” ...

The Supreme Court on Wednesday largely upheld the Food and Drug Administration’s denials of two companies’ applications to sell flavored liquids for use in e-cigarettes. In a unanimous ruling, the ...

Companies had sued the FDA, saying it unfairly shifted its standards for approving e-cigarette liquids popular with teens.